Clinical trial
The Effect of Entry Site Distance From Limbus on Perceived Pain During Intravitreal Injection of Anti-VEGF (Vascular Endothelial Growth Factor) Agents
NCT05640895 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Entry Site Distance From Limbus on Perceived Pain During Intravitreal Injection of Anti-VEGF (Vascular Endothelial Growth Factor) Agents
- Lead sponsor
- The University of Texas Medical Branch, Galveston
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 14, 2022
- Completion date
- September 9, 2024
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.